Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2011 3
2012 2
2013 3
2014 2
2015 12
2016 5
2017 5
2018 9
2019 9
2020 7
2021 10
2022 11
2023 13
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for anastasia strategy
Your search for Anastasia Stratigea retrieved no results
Critical considerations in N-glycoproteomics.
Chau TH, Chernykh A, Kawahara R, Thaysen-Andersen M. Chau TH, et al. Curr Opin Chem Biol. 2023 Apr;73:102272. doi: 10.1016/j.cbpa.2023.102272. Epub 2023 Feb 7. Curr Opin Chem Biol. 2023. PMID: 36758418 Review.
Giving the rapid maturation and, expectedly, a wide-spread implementation of N-glycoproteomics capabilities across the community in future years, this piece aims to point out common pitfalls, to encourage good data sharing and documentation practices, and to highlight practical s …
Giving the rapid maturation and, expectedly, a wide-spread implementation of N-glycoproteomics capabilities across the community in future y …
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study.
Luminari S, Manni M, Galimberti S, Versari A, Tucci A, Boccomini C, Farina L, Olivieri J, Marcheselli L, Guerra L, Ferrero S, Arcaini L, Cavallo F, Kovalchuk S, Skrypets T, Del Giudice I, Chauvie S, Patti C, Stelitano C, Ricci F, Pinto A, Margiotta Casaluci G, Zilioli VR, Merli A, Ladetto M, Bolis S, Pavone V, Chiarenza A, Arcari A, Anastasia A, Dondi A, Mannina D, Federico M; Fondazione Italiana Linfomi. Luminari S, et al. J Clin Oncol. 2022 Mar 1;40(7):729-739. doi: 10.1200/JCO.21.01234. Epub 2021 Oct 28. J Clin Oncol. 2022. PMID: 34709880 Clinical Trial.
Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin.
Tang Q, Fakih HH, Zain Ui Abideen M, Hildebrand SR, Afshari K, Gross KY, Sousa J, Maebius AS, Bartholdy C, Søgaard PP, Jackerott M, Hariharan V, Summers A, Fan X, Okamura K, Monopoli KR, Cooper DA, Echeverria D, Bramato B, McHugh N, Furgal RC, Dresser K, Winter SJ, Biscans A, Chuprin J, Haddadi NS, Sherman S, Yıldız-Altay Ü, Rashighi M, Richmond JM, Bouix-Peter C, Blanchard C, Clauss A, Alterman JF, Khvorova A, Harris JE. Tang Q, et al. Nat Commun. 2023 Nov 4;14(1):7099. doi: 10.1038/s41467-023-42714-4. Nat Commun. 2023. PMID: 37925520 Free PMC article.
Inhibition of Janus kinase (JAK) family enzymes is a popular strategy for treating inflammatory and autoimmune skin diseases. In the clinic, small molecule JAK inhibitors show distinct efficacy and safety profiles, likely reflecting variable selectivity for JAK subtypes. . …
Inhibition of Janus kinase (JAK) family enzymes is a popular strategy for treating inflammatory and autoimmune skin diseases. In the …
Brexpiprazole for treatment-resistant major depressive disorder.
Fornaro M, Fusco A, Anastasia A, Cattaneo CI, De Berardis D. Fornaro M, et al. Expert Opin Pharmacother. 2019 Nov;20(16):1925-1933. doi: 10.1080/14656566.2019.1654457. Epub 2019 Aug 20. Expert Opin Pharmacother. 2019. PMID: 31431092 Review.
The atypical antipsychotics represent a popular augmentation strategy for antidepressant-resistant depression, although their efficacy/safety profiles vary across different agents and presentations of depression. ...
The atypical antipsychotics represent a popular augmentation strategy for antidepressant-resistant depression, although their efficac …
Patient-Centered Research and Innovation in Nephrology.
Hughes A, Guha C, Sluiter A, Himmelfarb J, Jauré A. Hughes A, et al. Adv Kidney Dis Health. 2024 Jan;31(1):52-67. doi: 10.1053/j.akdh.2023.12.004. Adv Kidney Dis Health. 2024. PMID: 38403395 Review.
Findings from such research can enhance clinical practice and strengthen decision-making and policy to support better outcomes. We aim to outline principles and strategies for patient involvement in research, including setting research priorities, identifying and designing …
Findings from such research can enhance clinical practice and strengthen decision-making and policy to support better outcomes. We aim to ou …
Novel Drugs in Follicular Lymphoma.
Anastasia A, Rossi G. Anastasia A, et al. Mediterr J Hematol Infect Dis. 2016 Nov 1;8(1):e2016061. doi: 10.4084/MJHID.2016.061. eCollection 2016. Mediterr J Hematol Infect Dis. 2016. PMID: 27872741 Free PMC article. Review.
The impossibility of achieving a definite cure, have prompted investigations into the possible role of more active and less toxic strategies with innovative therapeutic agents. Recently Casulo et al. demonstrated that approximately 20% of patients with FL relapse within tw …
The impossibility of achieving a definite cure, have prompted investigations into the possible role of more active and less toxic strateg …
Orphan GPR116 mediates the insulin sensitizing effects of the hepatokine FNDC4 in adipose tissue.
Georgiadi A, Lopez-Salazar V, Merahbi RE, Karikari RA, Ma X, Mourão A, Klepac K, Bühler L, Alfaro AJ, Kaczmarek I, Linford A, Bosma M, Shilkova O, Ritvos O, Nakamura N, Hirose S, Lassi M, Teperino R, Machado J, Scheideler M, Dietrich A, Geerlof A, Feuchtinger A, Blutke A, Fischer K, Müller TD, Kessler K, Schöneberg T, Thor D, Hornemann S, Kruse M, Nawroth P, Pivovarova-Ramich O, Pfeiffer AFH, Sattler M, Blüher M, Herzig S. Georgiadi A, et al. Nat Commun. 2021 May 20;12(1):2999. doi: 10.1038/s41467-021-22579-1. Nat Commun. 2021. PMID: 34016966 Free PMC article.
Thus our findings will now allow for harnessing this endocrine circuit for alternative therapeutic strategies in obesity-related pre-diabetes....
Thus our findings will now allow for harnessing this endocrine circuit for alternative therapeutic strategies in obesity-related pre- …
RNAi-based drug design: considerations and future directions.
Tang Q, Khvorova A. Tang Q, et al. Nat Rev Drug Discov. 2024 Apr 3. doi: 10.1038/s41573-024-00912-9. Online ahead of print. Nat Rev Drug Discov. 2024. PMID: 38570694 Review.
In this Review, we discuss principal considerations and future directions in the design of therapeutic siRNAs, with a particular emphasis on chemistry, the application of informatics, delivery strategies and the importance of careful target selection, which together influe …
In this Review, we discuss principal considerations and future directions in the design of therapeutic siRNAs, with a particular emphasis on …
Physiological assessment after percutaneous coronary intervention: the hard truth.
Zimbardo G, Cialdella P, DI Giusto F, Migliaro S, Anastasia G, Petrolati E, Galante D, D'Amario D, Leone AM. Zimbardo G, et al. Panminerva Med. 2021 Dec;63(4):519-528. doi: 10.23736/S0031-0808.21.04363-9. Epub 2021 Sep 6. Panminerva Med. 2021. PMID: 34486363 Review.
Physiologically guided revascularization, using fractional flow reserve (FFR) or instantaneous wave free ratio (iFR) has been demonstrated to be associated with better long-term outcomes compared to an angiographically-guided strategy, mainly avoiding inappropriate coronar …
Physiologically guided revascularization, using fractional flow reserve (FFR) or instantaneous wave free ratio (iFR) has been demonstrated t …
Charcot-Marie-tooth disease type 2A: An update on pathogenesis and therapeutic perspectives.
Alberti C, Rizzo F, Anastasia A, Comi G, Corti S, Abati E. Alberti C, et al. Neurobiol Dis. 2024 Apr;193:106467. doi: 10.1016/j.nbd.2024.106467. Epub 2024 Mar 5. Neurobiol Dis. 2024. PMID: 38452947 Free article. Review.
Many treatment approaches, especially concerning molecular therapy, such as histone deacetylase inhibitors, peptide therapy to increase mitochondrial fusion, the new therapeutic strategies based on MF1/MF2 balance, and SARM1 inhibitors, are currently in preclinical testing …
Many treatment approaches, especially concerning molecular therapy, such as histone deacetylase inhibitors, peptide therapy to increase mito …
95 results